Comments

LENZ Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does LENZ Therapeutics (LENZ) operate in?

LENZ Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

LENZNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q4 2024 Earnings were released on Wed Mar 19th, after the market close

The most recent conference call was at 16:30 PM, 6 days ago Click to view past webcast

LENZ Therapeutics (LENZ) Forecast

News Earnings LENZ Therapeutics (LENZ) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

LENZ Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:LENZ | Benzinga

Explore LENZ Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LENZ.

Open	$26.59
Close	-
Volume / Avg.	179.08K / 172.82K
Day Range	$25.75 - $27.68
52 Wk Range	14.42 - 38.93
Market Cap	$726.31M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	61
Short Interest	17.67%
Days to Cover	27.56

Recent News

LENZ Therapeutics' Investigational Drug For Age-Related Blindness Aces Pivotal China Trial, Analyst Says Data Readout May Strengthen Position For Ex-U.S. Partnerships

LENZ Therapeutics and Corxel Pharmaceuticals announced Phase 3 data for LNZ100, showing significant presbyopia improvements, supporting potential FDA approval.

Vandana Singh

Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why LENZ Therapeutics Stock Hit A New 52-Week High Today

Lenz Therapeutics shares hit a new 52-week high during Monday's session. The company announced the FDA accepted its new drug application.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Nov 24

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$26.59
Close	-
Volume / Avg.	179.08K / 172.82K
Day Range	$25.75 - $27.68
52 Wk Range	14.42 - 38.93
Market Cap	$726.31M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	61
Short Interest	17.67%
Days to Cover	27.56

About LENZ Therapeutics Inc.

Sector

Health Care

Industry

Biotechnology

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercial...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy LENZ Therapeutics (LENZ) stock?

You can purchase shares of LENZ Therapeutics (NASDAQ:LENZ) through any online brokerage.

View our list of the best stock brokerages

Who are LENZ Therapeutics (LENZ) competitors?

Other companies in LENZ Therapeutics’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), Gyre Therapeutics (NASDAQ:GYRE), Valneva (NASDAQ:VALN) and Cogent Biosciences (NASDAQ:COGT).

What is the forecast, or price target, for LENZ Therapeutics (LENZ) stock?

LENZ Therapeutics has a consensus price target of $38.00.

What is the current price for LENZ Therapeutics (LENZ)?

The stock price for LENZ Therapeutics (NASDAQ: LENZ) is $26.37 last updated March 25, 2025 at 3:39 PM EDT.

Does LENZ Therapeutics (LENZ) pay a dividend?

A quarterly cash dividend of 1.03 per share of Class A Common Stock. The quarterly cash dividend was payable on March 22, 2024 to stockholders of record on March 15, 2024.

When is LENZ Therapeutics (NASDAQ:LENZ) reporting earnings?

LENZ Therapeutics’s Q4 earnings are confirmed for Wednesday, March 19, 2025.

Is LENZ Therapeutics (LENZ) going to split?

There is no upcoming split for LENZ Therapeutics.

What sector and industry does LENZ Therapeutics (LENZ) operate in?

LENZ Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.